Susquehanna International Group
MYOV

Susquehanna International Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Susquehanna International Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-155,900
Closed -$4.2M – 14054
2022
Q4 		$4.2M Sell
155,900
-7,500
-5% -$197K ﹤0.01% 3503
2022
Q3 		$2.94M Sell
163,400
-96,100
-37% -$1.53M ﹤0.01% 4146
2022
Q2 		$3.23M Buy
259,500
+110,700
+74% +$1.22M ﹤0.01% 3937
2022
Q1 		$1.98M Buy
148,800
+1,700
+1% +$22.8K ﹤0.01% 5506
2021
Q4 		$2.29M Sell
147,100
-55,500
-27% -$1.06M ﹤0.01% 5197
2021
Q3 		$4.55M Buy
202,600
+11,800
+6% +$259K ﹤0.01% 4129
2021
Q2 		$4.34M Buy
190,800
+121,100
+174% +$2.55M ﹤0.01% 4288
2021
Q1 		$1.43M Sell
69,700
-16,800
-19% -$382K ﹤0.01% 6772
2020
Q4 		$2.39M Buy
86,500
+67,500
+355% +$1.31M ﹤0.01% 4729
2020
Q3 		$267K Buy
19,000
+2,700
+17% +$50.2K ﹤0.01% 8950
2020
Q2 		$336K Buy
+16,300
New +$222K ﹤0.01% 8159
2020
Q1 		– Sell
-63,000
Closed -$978K – 11118
2019
Q4 		$978K Buy
+63,000
New +$635K ﹤0.01% 5578

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's MYOV Position: Q1 2023 in Review

Susquehanna International Group sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 25,615 shares — an estimated $691K sold.

Susquehanna International Group first reported a position in MYOV in Q2 2017 and held it in 13 quarters. The position peaked at $9.26M in Q4 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Susquehanna International Group reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 25,615 Myovant Sciences Ltd. shares in Q1 2023, an estimated $691K.
  • Susquehanna International Group first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 13 quarters.
  • Susquehanna International Group's Myovant Sciences Ltd. position peaked at $9.26M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.